CLINICAL_TRIALS trial_result · 2026-01-06

Clinical Trial Update: Study of LAU-7b for the Treatment of Long COVID in Adults [Phase 2, Phase 3]

Phase 2/3 clinical trial updates for LAU-7b in adults with post-acute sequelae of SARS-CoV-2 infection (Long COVID); results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Laurent Pharmaceuticals Inc. | Conditions: Long COVID | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2026-01-06